Deere & Company’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Deere & Company’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-11,161	Closed	-$167K	–	1163
2016 Q2	$167K	Hold	11,161	–	–	0.01%	986
2016 Q1	$136K	Buy	+11,161	New	+$157K	0.01%	964
2013 Q4	–	Sell	-24,705	Closed	-$504K	–	1130
2013 Q3	$504K	Buy	+24,705	New	+$550K	0.03%	648

Deere & Company's SGNT Position: Q3 2016 in Review

Deere & Company sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 11,161 shares — an estimated $167K sold.

Deere & Company first reported a position in SGNT in Q3 2013 and held it in 3 quarters. The position peaked at $504K in Q3 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Deere & Company reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Deere & Company sold 11,161 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $167K.
Deere & Company first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 3 quarters.
Deere & Company's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $504K in Q3 2013.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.